SPA Pricing Education, Analytics & Decision Making Tools Webinar Series

Tag: Health Services Pricing

Trump blasts Big Pharma again — “somebody’s getting very rich” — and promises drug price legislation | ENDPOINTS NEWS

Trump blasts Big Pharma again — “somebody’s getting very rich” — and promises drug price legislation | ENDPOINTS NEWS

On Mon­day Eli Lilly CEO Dave Ricks out­lined his com­pany’s case that their drug prices are not spin­ning out of con­trol. In a lengthy re­port he as­serted that dis­counts on drug prices to pharma ben­e­fit man­agers has grown from 28% in 2012 to an av­er­age of 50% last year. And while list prices grew 14% […]

Trump blasts Big Pharma again — “somebody’s getting very rich” — and promises drug price legislation | ENDPOINTS NEWS

Trump blasts Big Pharma again — “somebody’s getting very rich” — and promises drug price legislation | ENDPOINTS NEWS

On Mon­day Eli Lilly CEO Dave Ricks out­lined his com­pany’s case that their drug prices are not spin­ning out of con­trol. In a lengthy re­port he as­serted that dis­counts on drug prices to pharma ben­e­fit man­agers has grown from 28% in 2012 to an av­er­age of 50% last year. And while list prices grew 14% […]

There’s a Middle Ground in Amgen’s Drug-Price Battle | Bloomberg Gadfly

There’s a Middle Ground in Amgen’s Drug-Price Battle | Bloomberg Gadfly

The February news that Amgen Inc.’s cholesterol-lowering drug Repatha helped prevent heart attacks was one of the most exciting biotech events of the year, renewing faith in the drug’s blockbuster potential. But the full trial results behind that headline, which Amgen released on Friday, disappointed investors, sinking the company’s shares more than 6 percent. Repatha’s sales have […]

Direct primary care, a no-insurance healthcare model | Business Insider

Direct primary care, a no-insurance healthcare model | Business Insider

Dr. Bryan Hill spent his career working as a pediatrician, teaching at a university, and working at a hospital. But in March 2016, he decided he no longer wanted a boss. He took some time off, then one day he got a call asking if he’d be up for doing a house call for a […]

Stents pricing: Govt asks hospitals to make prompt refunds | The Economic Times

Stents pricing: Govt asks hospitals to make prompt refunds | The Economic Times

NEW DELHI: No action will be taken against hospitals under the scanner for overcharging on stents if they refund the money to patients before receiving a demand notice, drug price regulator NPPA said. The National Pharmaceutical Pricing Authority (NPPA) said the matter would end there for such hospitals if there were no further complaints. “If […]

Top hospitals under regulator’s lens for overcharging patients for stents | Times of India

Top hospitals under regulator’s lens for overcharging patients for stents | Times of India

NEW DELHI: Some of the country’s most prestigious hospitals are under the scanner of the National Pharmaceutical Pricing Authority (NPPA) for allegedly overcharging patients for stents. The regulator has initiated a probe against hospitals including PGIMER Chandigarh; Lilavati Hospital in Mumbai; Max Hospital in Saket, Delhi; Metro Hospital in Faridabad and Ballabhgarh (Haryana); and Ram […]

Pharma lobby launches crusade against Cuomo’s ‘flawed’ drug pricing plan in NY | FiercePharma

Pharma lobby launches crusade against Cuomo’s ‘flawed’ drug pricing plan in NY | FiercePharma

Pharma has heard enough of New York Governor Andrew Cuomo’s ideas for lowering drug prices. Just a month after the governor unveiled his plan, the industry’s trade group is rolling out a counteroffensive urging state officials to “Prescribe Real Solutions” instead. Gov. Cuomo’s plan would create a board to rule on “fair prices” for certain expensive […]

Sweden Reviews Financing and Pricing | CHCUK

Sweden Reviews Financing and Pricing | CHCUK

Review Under the current pricing and reimbursement system, medicinal products aimed at smaller patient groups (eg, orphan drugs) will have difficulty proving cost effectiveness within QALY thresholds used by the TLV, due to high research and development costs and a very high price per patient ratio. The effectiveness of such a medicinal product is also […]

National Pharmaceutical Pricing Authority slashes stent prices by up to 85% | Times of India

National Pharmaceutical Pricing Authority slashes stent prices by up to 85% | Times of India

The National Pharmaceutical Pricing Authority on Monday fixed the ceiling price of drug eluting stents (DES) and bioresorbable stents at Rs 30,000 and that of bare metal stents at Rs 7,500. The prices will be effective from notification on February 14. This comes as a huge relief to lakhs of patients who have to undergo […]

Drug Pricing 2017’s Challenge Confronting Biopharma | Life Science Leader

Drug Pricing 2017’s Challenge Confronting Biopharma | Life Science Leader

Although just a part of total healthcare costs, drug prices have certainly attracted a lot of comments from politicians and mentions in the press. If the issue was limited to being primarily a talking point exploited by politicians to generate populist support, it might be one thing; however, the politicians’ commentary is giving voice to […]